Show an ad over header. AMP

I am the FIRST

The next generation of coronavirus vaccines won't come as quickly

A flood of cash from Operation Warp Speed helped coax a slew of biotech companies into the race for a coronavirus vaccine, but the incentives to keep working on new competitors won't be nearly as strong.

Why it matters: That initial flood of cash worked — it delivered multiple, highly effective vaccines in record time. In other disease areas, though, second- and third-generation vaccines usually become the dominant products. And the first COVID-19 vaccines aren't necessarily a great fit for the whole world.

The big picture: Pfizer and Moderna's mRNA vaccines are extremely effective. And in the U.S. and other wealthy countries, their cold-storage requirements and multiple doses are easily manageable.

  • "The incentive to try to develop a vaccine that will try and take the place of a vaccine like that is not overwhelming," NIAID Director Anthony Fauci said.
  • The American government doesn't have much reason to pour more billions of dollars into subsequent research, and the vaccine market is highly dependent on governments and non-governmental organizations.

Yes, but: Each of the existing vaccines has some feature that makes it a less-than-perfect candidate for use in lower-income countries, and it's ultimately in rich countries' self-interest to vaccinate as much of the world as possible.

  • Pfizer and Moderna are both two shots and require very cold storage. AstraZeneca is two shots and has been plagued by bad headlines and safety concerns from European regulators. Johnson & Johnson is one shot, but it's also suffering some reputational damage due to extremely rare side effects.

The intrigue: Especially because so much of the remaining need will be in poorer countries, the traditional market incentives to develop a cheaper competing product don't really apply here.

  • “If you're trying to get another vaccine developed at a lower price, that’s probably not a good incentive” for drug companies, said Craig Garthwaite, a professor at Northwestern University.

"We now have performance standards ... for efficacy, safety, cost, ease of use, speed to develop new generation for coverage of variants, and scalability of manufacturing," said Krishna Udayakumar, founding director of the Duke Global Health Innovation Center. "New vaccines probably need to be better in one or more of those domains for longer term sustainability."

What we're watching: The vaccine pipeline isn't completely dry — Novavax is likely to seek authorization soon, and others are still in development.

  • "Access to capital may become harder going forward. But there seem to be several vaccine candidates still getting significant R&D support," Udayakumar said. Those include vaccines that use different platforms, and some that could be administered orally.
  • The existing vaccines makers also will keep working on their products: Pfizer is researching whether its vaccine can be stored at warmer temperatures, which would make it more accessible worldwide.
  • “I think you're going to see an intense interest on the part of countries that are low and middle income in getting access to the mRNA vaccines, and I think you're going to see the companies putting a lot of research into eliminating the cold chain requirements they have," Fauci said.

The bottom line: "You will always have individual investigators working on new platform technologies," Fauci said. "They will be done not at an Operation Warp Speed level. They will be done by individual grantees that come up with a concept."

Gas prices rise in several states as pipeline outage crimps supply

Gas stations in several statesare out of fuel and AAA reports the nationwide average price breached $3-per-gallon for the first time in six years amid the cyberattack-induced shutdown of the Colonial Pipeline.

Driving the news: The ransomware attack on Colonial Pipeline, the nation's largest refined fuel pipeline that extends from Texas into the Northeast, is creating a scramble as the outage persists into its sixth day.

Keep reading... Show less

Read: What Liz Cheney told the House GOP behind closed doors before her ouster

"If you want leaders who will enable and spread his destructive lies, I’m not your person, you have plenty of others to choose from," Rep. Liz Cheney (R-Wyo.) told House Republicans before they voted to remove her as the party's conference chair on Wednesday.

Why it matters: In her address, Cheney promised that she "will be leading the fight to restore our party" and make it "worthy again of being the party of Lincoln," signaling that she doesn’t plan on going anywhere soon and will continue to be a voice of dissent in the party.

Keep reading... Show less

House Republicans remove Liz Cheney from leadership over Trump opposition

House Republicans voted Wednesday to oust Rep. Liz Cheney (R-Wyo.) as conference chair, capping months of growing backlash over her criticisms of former President Trump, according to two sources in the room.

Why it matters: The stunning removal of the No. 3 House Republican over her condemnation of Trump's election lies reflects the influence the former president still retains over the GOP. It's the most significant turning point in an internal party feud that is unlikely to subside any time soon.

Keep reading... Show less

Biden names third slate of judicial nominees

President Biden on Wednesday announced a new slate of nominations for federal judges, with the president now having put forward 20 names to fill judicial vacancies.

Why it matters: The administration described the most recent picks as an embodiment of "the diversity of our nation," and said that Biden is continuing a trend of announcing judicial nominees at a record pace.

Keep reading... Show less

Consumer prices jumped 4.2% in April compared to last year

The latest gauge on inflation released Wednesday morning showed that prices rose 4.2% over last year, based on the Consumer Price Index (CPI).

Why it matters: The gains were highest since September 2008. Prices jumped significantly compared to the start of the pandemic last year, when lockdowns drove down demand.

Keep reading... Show less

What China's population woes mean for the rest of the world

China released its censusreport on Tuesday, showing that the number of births in the country last year dropped 18% from 2019. And China isn't alone — populations have been stagnating globally for decades, including in the U.S.

Why it matters: China has long relied on its large population — the biggest in the world — as a core engine for economic growth. The way that it, and officials across the globe, deal with changing demographics will lead to shifts in the economy and geopolitics.

Keep reading... Show less

Inside Liz Cheney's plans to continue fighting for soul of GOP after leadership ouster

As she faces a voteto be thrown out of House Republican leadership, Rep. Liz Cheney has told associates she doesn’t plan on going anywhere — and plans to run for re-election.

What to watch: In the meantime,as she sees it, she will aggressively pursue a fight for the soul of the Republican Party, after an expected vote to strip her of her post as GOP conference chair, the party's No. 3 House post.

Keep reading... Show less

Biden plans to send envoy as Israel and Hamas escalate toward war

Tel Aviv — With Israel and Hamas now engaged in their most destructive fight in seven years, the Biden administration is considering plans to dispatch a State Department official to join the de-escalation efforts, five Israeli officials and Western diplomats tell me.

Driving the news: The fighting intensified overnight, with Hamas and other militants firing a second barrage of over 100 rockets toward Tel Aviv and other nearby cities, and Israel continuing its air campaign in the Gaza Strip by destroying high-rise buildings, Hamas facilities and rocket units.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories